Skip to content

EV / sales at other companies

Select Medical Holdings logo
Select Medical HoldingsSEM
0.9×0.0×
Encompass Health Corporation logo
Encompass Health CorporationEHC
2.1×-0.3×
LifeStance Health Group logo
LifeStance Health GroupLFST
1.8×-0.4×
Concentra Group Holdings Parent logo
Concentra Group Holdings ParentCON
2.2×-0.4×
MSA
Mine Safety Appliances CompanyMSA
3.6×+0.2×
CBIZ logo
CBIZCBZ
1.2×-1.5×

Other financials

Income statement

See full
Revenue$198.3M+7.9%
Gross profit$32.8M+5.4%
Operating income$12.5M-36.5%
Net income$5.0M-49.1%
EPS (diluted)-$0.12-115%

Balance sheet

See full
Cash & equivalents$28.4M-27.4%
Total debt$169.4M+12.6%
Total equity$469.0M-5.7%
Total assets$1.2B+5.3%

Cash flow

See full
Operating cash flow$3.8M+181%
CapEx$5.4M+108%
Free cash flow-$1.6M+78.4%

Valuation

See full
Market cap$1.01B-10.7%
Enterprise value$1.15B-7.4%
P/E29×-4.9×
P/S1.3×-0.3×

Profitability

See full
Gross margin19%+0.9pp
Operating margin10%+0.3pp
Net margin4.4%-0.4pp
FCF margin8.4%+0.4pp

Returns & leverage

See full
Return on equity7.2%+0.4pp
Debt / equity0.4×+0.1×
Current ratio1.2×0.0×

Where this comes from

Calculated from US Physical Therapy’s reported figures.

Based on the most recent quarter.

The official record: US Physical Therapy’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about US Physical Therapy's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is US Physical Therapy's EV / sales?
US Physical Therapy (USPH) reported EV / sales of 1.6× in Q1 2026.
How has US Physical Therapy's EV / sales changed year-over-year?
US Physical Therapy's EV / sales decreased by 7.4% year-over-year, from 1.7× to 1.6×.
What is the long-term trend for US Physical Therapy's EV / sales?
Over 5 years (2020 to 2025), US Physical Therapy's EV / sales has grown at a -15.1% compound annual growth rate (CAGR), from 3.8× to 1.7×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.